EGFRm NSCLC: New Era in Upfront Treatment | EIOC Journal Club | Feb 2026 скачать в хорошем качестве

EGFRm NSCLC: New Era in Upfront Treatment | EIOC Journal Club | Feb 2026

Driving EGFRm NSCLC Care Forward - A New Era for EGFRm NSCLC Patients in the Upfront Setting | EIOC Journal Club Join leading oncology experts for an expert panel discussion on cutting-edge approaches to treating EGFR-mutated non-small cell lung cancer (EGFRm NSCLC) in the first-line setting. 📅 Originally Aired: February 11, 2026 ⏰ Time: 18:30-19:30 UAE Time ⏱️ Duration: 1 hour 🎯 Target Audience: Healthcare professionals in oncology and pulmonology Featured Expert Panel: • Dr. Shaheenah Dawood (UAE) - Moderator • Dr. Enriqueta Felip (Spain) • Dr. Abdulaziz Al Jassimi (Kuwait) • Dr. Dalia El Shorbagy (UAE) • Dr. Hassan Shahrayar (UAE) Key Topics Covered: ✓ Latest advances in EGFRm NSCLC upfront therapy ✓ First-line treatment strategies and sequencing ✓ Novel targeted therapies and combination approaches ✓ Biomarker-driven patient selection ✓ Real-world evidence and clinical trial insights ✓ Optimizing outcomes in EGFRm NSCLC patients Supported by: Johnson & Johnson Congress Secretariat: IADEX Conventions This complimentary educational session provides practicing healthcare professionals with practical insights on optimizing first-line treatment strategies for EGFR-mutated non-small cell lung cancer. 🔗 Catch up on previous sessions: apmeaoncology.com 🌐 More information: cancercongress.ae #LungCancer #NSCLC #EGFRMutation #EGFRmNSCLC #TargetedTherapy #Oncology #Pulmonology #MedicalEducation #UAE #CME #EIOC #JournalClub #APMEA #FirstLineTherapy